மருத்துவ சோதனை பாப்யுலேஶந்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருத்துவ சோதனை பாப்யுலேஶந்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருத்துவ சோதனை பாப்யுலேஶந்ஸ் Today - Breaking & Trending Today

Improving Diversity In Clinical Trials


Improving Diversity In Clinical Trials
Source: Life Science Leader
The lack of diversity in clinical trials isn’t a new problem, but in 2020 this issue rose to the forefront of the industry as a spotlight was cast on drug development as a whole due to the COVID pandemic. In fact, a key milestone related to this topic came in November 2020 when the FDA issued its final guidance, Enhancing the Diversity of Clinical Trial Populations Eligibility Criteria, Enrollment Practices, and Trial Designs. The experts in this ebook come from varying backgrounds, and as such, offer a myriad of recommendations relating to improving clinical trial enrollment of racial and ethnic minority groups ....

Clinical Trial Populations , Eligibility Criteria , Enrollment Practices , மருத்துவ சோதனை பாப்யுலேஶந்ஸ் , தகுதி அளவுகோல்கள் , சேர்க்கை ப்ர்யாக்டிஸஸ் ,

COVID proves clinical trials must proactively recruit people of color


COVID proves clinical trials must proactively recruit people of color
Jo Wiederhorn, opinion contributor
© Getty Images
COVID proves clinical trials must proactively recruit people of color
In the year since the start of the COVID-19 pandemic and the subsequent death of more than 500,000 Americans, researchers around the world have raced to develop vaccines at an unprecedented pace. But the quest to stop the pandemic in its tracks has collided with a long-standing problem: the lack of diversity in clinical trials. This issue must be addressed and the new federal administration can help.
The Centers for Disease Control and Prevention report that Black Americans are 1.1 times as likely as white Americans to contract COVID-19, 2.9 times as likely to end up in the hospital and nearly twice as likely to die from it. Yet the communities hardest hit by illnesses like COVID-19 are also those grossly underrepresented in clinical trials for cures and ....

New York , United States , Columbia University , Lawrences Honig , Lynne Richardson , Carol Horowitz , Centers For Disease , York Center , National Institutes Of Alzheimer Disease Research Center , Icahn School Of Medicine At Mount Sinai , Institute For Health Equity Research , Food Drug Administration , Biden Administration Do , Getty Images , Disease Control , Black Americans , Drug Administration , African American , Emergency Medicine , Health Equity Research , Icahn School , Mount Sinai , New York State Funded Center , National Institutes , Health Funded Alzheimer , Disease Research Center ,